GLP-1 clinical trials in North Carolina: 31 recruiting now

74 sites in 17 North Carolina cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (11)

Weight-loss study of cagrisema

Where: Greensboro, Greenville, Morehead City and 2 more cities

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

PharmQuest Life Sciences LLC, Greensboro

Physician's East Endocrinology, Greenville

Carteret Medical Group, Morehead City

Centricity Rsrch MHCity Multi, Morehead City

Piedmont Healthcare/Research, Statesville

and 1 more site

Accellacare Wilmington, Wilmington

Weight-loss study of maridebart cafraglutide

Where: Morehead City, Raleigh and Wilmington

What: Tests whether a study medicine from Amgen, Maridebart Cafraglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity or overweight, BMI 25+.

Study record on ClinicalTrials.gov

Centricity Research Morehead City Specialty, Morehead City

Accellacare of Raleigh, Raleigh

Accellacare Research of Wilmington, Wilmington

Show 8 more studies

Weight-loss study of semaglutide

Where: Greensboro and Statesville

What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.

Free to join

Who can join: Adults 18+ who are overweight.

Study record on ClinicalTrials.gov

PharmQuest Life Sciences LLC, Greensboro

Piedmont Healthcare/Research, Statesville

Weight-loss study of cagrilintide

Where: Greensboro and Wilmington

What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.

Free to join

Who can join: Adults 18+ who are overweight, BMI 27+.

Study record on ClinicalTrials.gov

PharmQuest, Greensboro

KDCILM, LLC & Accellacare US, Inc., Wilmington

Weight-loss study of tirzepatide

Where: Monroe and Wilmington

What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with obesity lose weight.

Free to join

Who can join: Adults 18+ with obesity.

Study record on ClinicalTrials.gov

Monroe Biomedical Research, Monroe

Accellacare - Wilmington, Wilmington

Weight-loss study of orforglipron

Where: Morehead City

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.

Free to join

Who can join: Children and teens 12 to 17 with obesity.

Study record on ClinicalTrials.gov

Lucas Research, Inc., Morehead City

Weight-loss study of cagrilintide

Where: Monroe and Wilmington

What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 30+.

Study record on ClinicalTrials.gov

Monroe Biomedical Research, LLC, Monroe

Accellacare, Wilmington

Type 2 diabetes studies (6)

Type 2 diabetes study of semaglutide

Where: Durham, Morehead City, Raleigh and 2 more cities

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Durham

Research Site, Morehead City

Research Site, Raleigh

Research Site, Statesville

Research Site, Wilmington

Type 2 diabetes study of survodutide

Where: Fayetteville, Greensboro and Morehead City

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Javara Inc. - Cape Fear Valley Medical Center, Fayetteville. 833-602-2368

PharmQuest Life Sciences, Greensboro. 833-602-2368

Centricity Research - Morehead City, Morehead City. 833-602-2368

Type 2 diabetes study of cagrisema

Where: Greensboro and Wilmington

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 25+.

Study record on ClinicalTrials.gov

PharmQuest Life Sciences LLC, Greensboro

Accellacare Wilmington, Wilmington

Show 3 more studies

Type 2 diabetes study of NNC0662-0419

Where: Greensboro and Statesville

What: Tests whether an investigational medicine from Novo Nordisk, NNC0662-0419, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18 to 75 with type 2 diabetes.

Study record on ClinicalTrials.gov

PharmQuest, Greensboro

Piedmont Healthcare Statesville, Statesville

Type 2 diabetes study of UBT251

Where: Greensboro and Wilmington

What: Tests whether an investigational medicine from Novo Nordisk, UBT251, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18 to 75 with type 2 diabetes.

Study record on ClinicalTrials.gov

PharmQuest, Greensboro

KDCILM, LLC & Accellacare US, Inc., Wilmington

Other GLP-1 studies in North Carolina (14)

Fatty liver disease with liver scarring study of survodutide

Where: Durham, Fayetteville, Greenville and 2 more cities

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Duke University Medical Center, Durham. 833-602-2368

Coastal Research Institute, LLC, Fayetteville. 833-602-2368

Carolina Researche, Greenville. 833-602-2368

Centricity Research (New Bern), New Bern. 833-602-2368

M3 Wake Research, Inc., Raleigh. 833-602-2368

Prehypertension study of orforglipron

Where: Greensboro, Monroe, Morehead City and 1 more city

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.

Free to join

Who can join: Adults 18+ who are overweight, BMI 25+.

Call the site: 336-763-6968Study record on ClinicalTrials.gov

Medication Management, Greensboro. 336-763-6968

Monroe Biomedical Research, Monroe

West Clinical Research, Morehead City. 252-515-0050

Trial Management Associates - Wilmington - Floral Parkway, Wilmington

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Fayetteville, Greenville and Raleigh

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Coastal Research Institute, LLC, Fayetteville. 833-602-2368

Carolina Researche, Greenville. 833-602-2368

M3 Wake Research, Inc., Raleigh. 833-602-2368

Show 11 more studies

Fatty liver disease (MASLD) study of retatrutide

Where: Durham, Monroe and Morehead City

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Call the site: 704-283-7359Study record on ClinicalTrials.gov

Duke University - Main Hospital and Clinics, Durham

Monroe Biomedical Research, Monroe. 704-283-7359

Carteret Medical Group, Morehead City. 252-499-8623

Alcohol use disorder study of semaglutide

Where: Asheville and Durham

What: Tests whether a GLP-1 medicine, semaglutide, can help people with alcohol use disorder drink less.

Free to join

Who can join: Adults 18 to 80 with alcohol use disorder, BMI 21+.

Call the site: 8282987911Study record on ClinicalTrials.gov

Asheville VA Medical Center, Asheville, NC, Asheville. 8282987911

Durham VA Medical Center, Durham, NC, Durham

Ulcerative colitis study of tirzepatide

Where: Fayetteville

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.

Study record on ClinicalTrials.gov

Coastal Research Institute - Fayetteville, Fayetteville

Crohn's disease study of tirzepatide

Where: Fayetteville

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.

Free to join

Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.

Study record on ClinicalTrials.gov

Coastal Research Institute - Fayetteville, Fayetteville

Psoriasis study of tirzepatide

Where: Cary and Huntersville

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people calm psoriasis.

Free to join

Who can join: Adults 18+ with psoriasis, BMI 27+.

Call the site: 800-785-3150Study record on ClinicalTrials.gov

Revival Research Institute, LLC, Cary

Onsite Clinical Solutions - Huntersville, Huntersville. 800-785-3150

Idiopathic intracranial hypertension (IIH) study of tirzepatide

Where: Durham

What: Tests a GLP-1 and GIP medicine, tirzepatide, in people with idiopathic intracranial hypertension (IIH).

Free to join

Who can join: Adults 18 to 60 with idiopathic intracranial hypertension (IIH), BMI 30+.

Call the site: 919-660-1754Study record on ClinicalTrials.gov

Duke University Medical Center, Durham. 919-660-1754

Chronic kidney disease study of NNC0519-0130

Where: Morehead City and Winston-Salem

What: Tests whether an investigational medicine from Novo Nordisk, NNC0519-0130, can help people with chronic kidney disease protect their kidneys.

Free to join

Who can join: Adults 18+ with chronic kidney disease, BMI 27+.

Study record on ClinicalTrials.gov

Carteret Medical Group, Morehead City

Brookview Hills Research Associates, LLC, Winston-Salem

Endometrial cancer study of tirzepatide

Where: Chapel Hill

What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people with endometrial cancer lose weight.

Free to join

Who can join: Adults 18+, women only with endometrial cancer, BMI 30+.

Call the site: 919-966-5996Study record on ClinicalTrials.gov

Lineberger Comprehensive Cancer Center, Chapel Hill. 919-966-5996

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.